文献速递间质性肺疾病

肌肉减少症与肌力减退是间质性肺疾病死亡的危险因素

Dynapenia and Sarcopenia as Risk Factors for Mortality in Interstitial Lung Disease.
PubMed 文献 · Respirology · 2025-02-04

调整混杂因素后,肌力减退(HR 2.04)和肌肉减少症(HR 1.88)均为死亡的独立危险因素。肌力减退患病率45%,肌肉减少症29%。

要点

  • 肌力减退是ILD患者死亡的独立危险因素(HR 2.04,95%CI 1.10-3.77)。
  • 肌肉减少症是ILD患者死亡的独立危险因素(HR 1.88,95%CI 1.00-3.33)。
  • CHP患者肌力减退和肌肉减少症患病率较高(分别为61%和50%)。

核心结论

  • 肌肉减少症和肌力减退是间质性肺疾病患者死亡的独立危险因素。

研究设计与样本

  • ILD分为IPF(33.66%)、CTD-ILD(47.96%)和CHP(18.37%);平均年龄63.89±12.02岁,男性37.76%。

主要发现

  • 调整混杂因素后,肌力减退与死亡风险升高相关(HR 2.04,95%CI 1.10-3.77,p=0.022)。
  • 肌肉减少症与死亡风险升高相关(HR 1.88,95%CI 1.00-3.33,p=0.049)。
  • 运动耐量与死亡风险相关(HR 0.99,95%CI 0.99-0.99,p=0.023)。
  • 肌力减退总体患病率45%,IPF 51%、CTD-ILD 35%、CHP 61%。
  • 肌肉减少症总体患病率29%,IPF 39%、CHP 50%、CTD-ILD 14%。

关键数值与推荐

  • 肌力减退和肌肉减少症依据EWGSOP2标准判定。

临床怎么用

  • 对ILD患者可评估肌力减退和肌肉减少症,以识别死亡风险较高者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Fibrotic interstitial lung disease (ILD) is associated with high morbidity and mortality. Patients often exhibit impaired nutritional status and alterations in body composition, such as dynapenia and sarcopenia, which correlate with poor pulmonary function, reduced exercise tolerance and diminished quality of life. However, the impact of dynapenia and sarcopenia on prognosis has not been examined extensively in ILD patients. We assessed the impact of dynapenia and sarcopenia as risk factors for mortality and their prevalence in ILD. METHODS: Prospective cohort study. ILD was classified into idiopathic pulmonary fibrosis (IPF), connective tissue disease-related ILD (CTD-ILD) and chronic hypersensitivity pneumonitis (CHP). Patients over 18 years old with a confirmed diagnosis of ILD were included, while those with diagnoses of cancer, human immunodeficiency virus and neurological disease were excluded. Dynapenia and sarcopenia were determined according to EWGSOP2 criteria. RESULTS: Ninety-eight ILD patients were included; 33.66% had IPF, 47.96% had CTD-ILD, and 18.37% had CHP. The mean age was 63.89 ± 12.02 years; 37.76% were male. The risk factors associated with mortality included dynapenia (HR: 2.04, 95% CI: 1.10-3.77, p = 0.022), sarcopenia (HR: 1.88, 95% CI; 1.00-3.33, p = 0.049) and exercise tolerance (HR: 0.99, 95% CI; 0.99-0.99, p = 0.023), adjusted for confounding variables. The prevalence of dynapenia was 45% in ILD; 51% in IPF, 35% in CTD-ILD and 61% in CHP. The prevalence of sarcopenia was 29%; both IPF (39%) and CHP (50%) had a higher prevalence of sarcopenia than CTD-ILD (14%). CONCLUSION: Sarcopenia and dynapenia are independent risk factors for mortality in ILD.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Ibarra-Fernández AA, Robles-Hernández R, Orea-Tejeda A, et al. Dynapenia and Sarcopenia as Risk Factors for Mortality in Interstitial Lung Disease. Respirology. 2025. PMID: 39905591. doi:10.1111/resp.14892

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。